why choose us

First received: February 08, 2023

Clinical Trial: A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Liver Diseases

Study Type: INTERVENTIONAL


Official Title: Pharmacokinetics, Safety, and Tolerability of BI 690517 in Subjects With Mild and Moderate Liver Impairment (Child-Pugh Classification A and B) as Compared to Healthy Subjects

Brief Summary: The main objective of this trial is to assess the effect of mild and moderate hepatic impairment (Child-Pugh classification A and B) on the pharmacokinetics, safety, and tolerability of BI 690517 in comparison with a control group with normal hepatic function.

Read more